Alexander Zverev sets up final against Felix Auger Aliassime in Cologne

Alexander Zverev sets up final against Felix Auger Aliassime in Cologne

"I had a very tough final in NY and, the next final I played here, I wanted to come out and play my best tennis", said Zverev after earning his first title in 17 months.

Felix Auger Aliassime and Alexander Zverev are going to face off in the final in Cologne.

"Felix, you're an unbelievable player". Zverev's previous title was at the clay-court Geneva Open in May 2019 and he is now 12-8 in career finals.

A classy Zverev concurred telling Auger-Aliassime: "You're not only going to win one title, but multiple titles in your career". At last year's Davis Cup final he fell in straight sets to the Spaniard, 7-6 (3), 6-3.

The 22-year-old Rublev added the title in Russian Federation to trophies in Doha, Adelaide and Hamburg.

Rublev extended his winning streak to 10 matches on home soil, having lifted the Kremlin Cup trophy in Moscow past year.

Bautista Agut came out on top for 2.5 hours to beat Hubert Hurkacz 7-6 (4), 5-7, 6-0, and Auger-Aliassime had less difficulty against Radu Albot, winning 6-3, 6- 0.

Russia's Andrey Rublev edged closer to a maiden appearance in the ATP Finals on Saturday when he defeated fellow London season-finale hopeful Denis Shapovalov to reach the Saint Petersburg final. Serving at 4-2, Alexander fended off two break chances, having a chance to seal the deal in game nine.

The Serb started the second set on the front foot and almost took a 3-0 lead before the home favourite mounted a comeback. Still, given the fact Zverev was not giving up any loose errors on key points, Auger-Aliassime would have been wise to either attack net more or try to bring his opponent forward at times.

"I'm very happy for this", he said. "There are so many positive things from the past few weeks".

The German world number seven claimed his third ATP Tour win on home soil as third seed Auger-Aliassime lost his sixth successive final.

Related Articles

  • Twitter CEO says blocking New York Post article without context was wrong

    Twitter CEO says blocking New York Post article without context was wrong

    That finally wound up within the palms of Giuliani, who supplied the newspaper with a duplicate of the information. The rapid-fire changes have made Twitter and Facebook the butt of jokes and invigorated efforts to regulate them.
    Australia's Victoria registers only one Covid-19 case

    Australia's Victoria registers only one Covid-19 case

    From Nov 1, remaining retail and restaurants, cafes, pubs and services such as beauty salons will reopen. Mr Andrews noted that daily cases in his state and the United Kingdom were comparable back in August.
    AB de Villiers most impactful player in the IPL: Kohli

    AB de Villiers most impactful player in the IPL: Kohli

    In four overs today he bowled 12 dots, maintaining that outstanding 50% ratio of dots into his fourth game now (48 dots/96 balls). Jofra Archer could have pushed that equation further, but Steve Smith entrusted Jaydev Unadkat to bowl the 19th.
  • Pfizer eyes emergency use approval for vaccine in November

    Pfizer eyes emergency use approval for vaccine in November

    Sanofi SA and GlaxoSmithKline Plc are also working on developing a vaccine they say could be authorized next year. A BioNTech spokeswoman confirmed the time frame for the possible EUA application to the FDA .
    The Funniest Tweets about the Biden and Trump Town Halls

    The Funniest Tweets about the Biden and Trump Town Halls

    A total of 11 million people tuned in to watch Mr Trump via NBC alone, while MSNBC provided 1.8 million viewers and CNBC 700,000. Provisional figures following yesterday's bout found almost 28 million people in total turned out to watch the candidates.
    Twitter appears to backtrack on blocking New York Post article

    Twitter appears to backtrack on blocking New York Post article

    Trump, who trails Biden in polls 19 days before the presidential election, blasted the two social media giants on Wednesday. The emails were discovered by President Donald Trump's allies.
  • Experts slam ‘dangerous fallacy’ of virus herd immunity

    Experts slam ‘dangerous fallacy’ of virus herd immunity

    It is illogical to ignore public health and scientific evidence when so many lives are at stake", the joint statement reads . George Rutherford, an infectious disease specialist at the University of California-San Francisco.
    You Can Now Google Search Songs By Singing, Humming And Whistling Them

    You Can Now Google Search Songs By Singing, Humming And Whistling Them

    One does not need to be pitch flawless for the feature to work and Google will show the most likely options based on the tune. After you're completed buzzing, Google's machine studying algorithm will determine the potential track matches .
    Blood type could be linked to Covid-19 risk and severity

    Blood type could be linked to Covid-19 risk and severity

    Adalja said that blood types and their susceptibility to various infections have been studied in the medical literature before. Kristina Box on Wednesday said that she, an adult daughter and 23-month-old grandson have tested positive for COVID-19.
  • Hollywood singer Sia supports Johnny Depp

    Hollywood singer Sia supports Johnny Depp

    She also sent out another tweet to Heard's ex-boyfriend Elon Musk, who Heard dated for roughly a year before they split in 2018. Sia asked him why he still protecting him after doing all those things for her? 'She still came out seven million richer.
    IPhone 12 Pre-Orders: How to Prepare

    IPhone 12 Pre-Orders: How to Prepare

    So it's not surprising that among all the online chat in China about the new iPhone there was a lot of moaning about the cost. If we consider the iPhone 12 with 128 GB of storage memory, the cheapest smartphone can be purchased in the United States.
    Russia Readies Approval For Second Covid-19 Vaccine

    Russia Readies Approval For Second Covid-19 Vaccine

    It's based on technology similar to that used by one of the fastest-moving vaccine developers, Moderna Inc. It might publish results of phase II clinical trials by early November.